Last edition
News about "oncology biosimilars "
BioDlink Launches Bevacizumab Biosimilar in Colombia and Pakistan
BioDlink’s bevacizumab injection secures marketing authorization in Colombia and Pakistan following its recent approval in Nigeria.<br />
Oncology Biosimilars | 14/08/2025 | By Dineshwori | 114
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members